Literature DB >> 18729028

[Overall burden to society caused by hyperkinetic syndrome (HKS) and attention deficit hyperactivity disorder (ADHD)].

O Schöffski1, S Sohn, M Happich.   

Abstract

OBJECTIVE: The purpose of this work was to provide an analysis of medical costs for HKS/ADHD on the basis of a cost-of-illness study.
METHODS: A systematic literature review concerning the direct and indirect costs of HKS/ADHD and its related implications was complemented by a special analysis of the German Federal Office of Statistics on ICD-10 F 90.
RESULTS: An analysis of overall medical costs by the Federal Office of Statistics results in expenses of 142 million euro in 2002 corresponding to ca. 630 euro per patient per year. These values are considerably below the values calculated for the USA. Increased indirect costs related to different implications of the indication were stated in international studies.
CONCLUSION: A first estimate of the direct costs for HKS/ADHS in Germany has been conducted. A reduction of the difference between the German and the US direct cost values may be expected. An increased level of the indirect costs related to HKS/ADHD may be assumed for Germany and requires further research.

Entities:  

Mesh:

Year:  2008        PMID: 18729028     DOI: 10.1055/s-0028-1082049

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  7 in total

1.  Treatment costs of attention deficit hyperactivity disorder in Germany.

Authors:  Sebastian Braun; Jan Zeidler; Roland Linder; Susanne Engel; Frank Verheyen; Wolfgang Greiner
Journal:  Eur J Health Econ       Date:  2012-11-21

2.  Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis.

Authors:  Mike Klora; Jan Zeidler; Roland Linder; Frank Verheyen; J-Matthias Graf von der Schulenburg
Journal:  Health Econ Rev       Date:  2015-12-21

3.  Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany.

Authors:  Peter Greven; Vanja Sikirica; Yaozhu J Chen; Tammy G Curtice; Charles Makin
Journal:  Eur J Health Econ       Date:  2016-11-05

4.  Italian regional health service costs for diagnosis and 1-year treatment of ADHD in children and adolescents.

Authors:  Gianluigi Casadei; Massimo Cartabia; Laura Reale; Maria Antonella Costantino; Maurizio Bonati
Journal:  Int J Ment Health Syst       Date:  2017-04-28

5.  Outpatient rehabilitation resources and medical expenditure in children with attention-deficit hyperactivity disorder in Taiwan.

Authors:  Hsing-Jung Li; Chao-Chan Kuo; Yi-Chien Yao; Ching-Hong Tsai; Philip C Chow; Ying-Chun Li
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

6.  ADHD in children and adolescents in Germany. Results of the cross-sectional KiGGS Wave 2 study and trends.

Authors:  Kristin Göbel; Franz Baumgarten; Benjamin Kuntz; Heike Hölling; Robert Schlack
Journal:  J Health Monit       Date:  2018-09-19

7.  Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case.

Authors:  Hoa H Le; Paul Hodgkins; Maarten J Postma; Jennifer Kahle; Vanja Sikirica; Juliana Setyawan; M Haim Erder; Jalpa A Doshi
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-10-29       Impact factor: 4.785

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.